Assignee
BIOVAXYS INC
US·1 granted patent·4 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
5 records- 0167US12042537B2Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjectsBIOVAXYS INC·Filed 2022·Granted Jul 23, 2024·0 cites·19 claims
- 0253US2024207381A1Bihaptenized autologous vaccines and uses thereofBIOVAXYS INC·Filed 2022·Application pending·0 cites
- 0351US2023398206A1Method and kit for detection of cell mediated immune responseBIOVAXYS INC·Filed 2021·Application pending·0 cites
- 0451US2023149534A1Haptenized coronavirus spike proteinsBIOVAXYS INC·Filed 2021·Application pending·0 cites
- 0547US2022047703A1Bihaptenized autologous vaccines and uses thereofBIOVAXYS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →